98 related articles for article (PubMed ID: 19210135)
1. A comparison of the pharmacokinetics of two different formulations of extended-release niacin.
Lauring B; Rosko K; Luo WL; Wenning L; Kissling J; Roupe K; Paolini JF; Wagner J; Lai E
Curr Med Res Opin; 2009 Jan; 25(1):15-22. PubMed ID: 19210135
[TBL] [Abstract][Full Text] [Related]
2. The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
Menon R; Tolbert D; Cefali E
Biopharm Drug Dispos; 2007 Sep; 28(6):297-306. PubMed ID: 17571283
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of niacin, simvastatin and their metabolites in healthy Chinese subjects after single and multiple doses of a fixed dose combination tablet of niacin extended release/simvastatin.
Liu M; Wang XL; Zhang D; Yang M; Han J; Zhang YN; Wang ZL; Liu HC
Drug Res (Stuttg); 2014 Jun; 64(6):296-300. PubMed ID: 24154936
[TBL] [Abstract][Full Text] [Related]
5. Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
Kesisoglou F; Rossenu S; Farrell C; Van Den Heuvel M; Prohn M; Fitzpatrick S; De Kam PJ; Vargo R
J Pharm Sci; 2014 Nov; 103(11):3713-3723. PubMed ID: 25256703
[TBL] [Abstract][Full Text] [Related]
6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
7. Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects.
Kosoglou T; Zhu Y; Statkevich P; Triantafyllou I; Taggart W; Xuan F; Kim KT; Cutler DL
Eur J Clin Pharmacol; 2011 May; 67(5):483-92. PubMed ID: 21120461
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
9. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
10. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Bittner B; Riek M; Holmes B; Grange S
Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
[TBL] [Abstract][Full Text] [Related]
12. Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects.
Lauring B; Dishy V; De Kam PJ; Crumley T; Wenning L; Liu F; Sisk C; Wagner J; Lai E
Am J Ther; 2015; 22(5):367-76. PubMed ID: 24832384
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in pharmacokinetics of a combination tablet of niacin extended-release/simvastatin in healthy Chinese volunteers.
Wang XL; Liu M; Yang M; Zhang YN; Zhang D; Zhang LN; Han J; Liu HC
Eur J Drug Metab Pharmacokinet; 2014 Dec; 39(4):321-6. PubMed ID: 24346851
[TBL] [Abstract][Full Text] [Related]
14. A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
Leibowitz MT; Zamora CA; Brzeczko AW; Stark JG
Am J Ther; 2014; 21(2):99-105. PubMed ID: 22357166
[TBL] [Abstract][Full Text] [Related]
15. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
[TBL] [Abstract][Full Text] [Related]
16. The bioavailability of sustained release nicotinic acid formulations.
Neuvonen PJ; Roivas L; Laine K; Sundholm O
Br J Clin Pharmacol; 1991 Oct; 32(4):473-6. PubMed ID: 1958442
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and bioequivalence study of sugar-coated and film-coated eperisone tablets in healthy subjects: A randomized, open-label, three-way, reference-replicated crossover study
.
Lee HJ; Ha ES; Lee Y; Ha DC; Choi YW; Baek IH; Kim MS
Int J Clin Pharmacol Ther; 2019 Jan; 57(1):55-62. PubMed ID: 30415650
[TBL] [Abstract][Full Text] [Related]
18. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
